Research SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study Anders Husby, Jørgen Vinsløv Hansen, Emil Fosbøl, et al BMJ 2021; 375 doi: https://doi.org/10.1136/bmj-2021-068665 (Published 16 December 2021)Cite this as: BMJ 2021;375:e068665 Abstract Objective To investigate the association between SARS-CoV-2 vaccination and myocarditis or myopericarditis. Design Population based cohort study. Setting D...

ARTICLES|ONLINE FIRST Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study Tommy Nyberg, Neil M Ferguson, Sophie G Nash, et al Lancet Published:March 16, 2022 DOI:https://doi.org/10.1016/S0140-6736(22)00462-7 Summary Background The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility,...

Original Investigation Caring for the Critically Ill PatientMarch 1, 2022 Association of Acute Respiratory Failure in Early Childhood With Long-term Neurocognitive Outcomes R. Scott Watson, Sue R. Beers, Lisa A. Asaro, et al JAMA. 2022;327(9):836-845. doi:10.1001/jama.2022.1480 Key Points Question  Do children with previously normal neurocognitive function who survive an episode of acute respiratory failure requiring intensive care ...

ICU Management & Practice, Volume 21 - Issue 6, 2021 The Importance of Accurate Glucose Monitoring in Critically Ill Patients The complexity of glucose testing, the limitations of point-of-care blood glucose monitoring systems and the need for accuracy and reliability to ensure optimised patient outcomes. Critically ill patients are not found just in intensive care units, but throughout the hospital: emergency departments, post-anaesthesia care units, op...

Research Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study Katia J Bruxvoort, Lina S Sy, Lei Qian, et al BMJ 2021; 375 doi: https://doi.org/10.1136/bmj-2021-068848 (Published 15 December 2021)Cite this as: BMJ 2021;375:e068848 Abstract Objectives To evaluate the effectiveness of the mRNA-1273 vaccine against SARS-CoV-2 variants and assess its effectiveness against the delta variant...

ONLINE FIRST (FREE ACCESS) LATEST ARTICLES Originals Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort studyAngriman F. et al. OPEN ACCESS ~ Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysisKochanek M. et al. Factors associated with acute mesenteric ischemia among critically ill ventilated patie...

ORIGINAL ARTICLE Population Immunity and Covid-19 Severity with Omicron Variant in South Africa Shabir A. Madhi, Gaurav Kwatra, Jonathan E. Myers, et al N Engl J Med February 23, 2022DOI: 10.1056/NEJMoa2119658 Abstract BACKGROUND The B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South Africa. Data regarding the seroprevalence of SARS-CoV-2 IgG in...

ICU Management & Practice, Volume 21 - Issue 6, 2021 Emergencies in Malignant Haematology for the Intensivist An overview of emergencies that are commonly seen in malignant haematology, side effects of novel therapies, and complications of allogeneic haematologic stem cell transplant. Introduction Critical illness is common in patients with haematologic malignancies. Recent data demonstrate that 14% of patients will require ICU admission within one ye...

Research Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial BMJ 2022; 376 doi: https://doi.org/10.1136/bmj-2021-068407 (Published 07 January 2022)Cite this as: BMJ 2022;376:e06840 Abstract Objective To assess the effect of statin treatment versus placebo on clinical outcomes in patients with covid-19 admitted to the intensive care unit (ICU). Design INSPIRATION/IN...

COMMENT| VOLUME 10, ISSUE 3, P223-224, MARCH 01, 2022 Stimulating severe COVID-19: the potential role of GM-CSF antagonism Helen L Leavis, Frank L van de Veerdonk, Srinivas Murthy Lancet Respir Med 2022; 10: 223-224 Over the past 20 months of the COVID-19 pandemic, a great deal has been crystallised about the ideal therapeutic targets for infected patients. For very sick patients who require hospitalisation, we now know that targeting the dysreg...